Treatment of chronic pleural effusion with pleuroperitoneal shunts in dogs: 14 cases (1985–1999)
Authors:
- Stephen J. BirchardSBStephen J. Birchard
- Mary A. McLoughlinMMMary A. McLoughlin
- Michelle M. LindseyMLMichelle M. Lindsey
- David E. HoltDHDavid E. Holt
- Dennis D. CaywoodDCDennis D. Caywood
- Myron O. DownsMDMyron O. Downs
- 1 December 2001
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 219 (11) , 1590-1597
Abstract
Objective—To describe complications and outcome associated with chronic nonseptic pleural effusion treated with pleuroperitoneal shunts in dogs. Design—Retrospective study. Animals—14 dogs. Procedure—Medical records at 4 veterinary schools were examined to identify dogs with chronic nonseptic pleural effusion that were treated by use of a pleuroperitoneal shunt between 1985 and 1999. Signalment, history, physical examination and laboratory findings, cause and type of pleural effusion, medical and surgical treatments, complications, and outcome were reviewed. Results—10 of 14 dogs had idiopathic chylothorax, and 4 had an identified disease. All but 1 dog with idiopathic chylothorax and 1 dog with chylothorax from a heart base tumor had unsuccessful thoracic duct ligation prior to pump placement. No intraoperative complications developed during shunt placement. Short-term complications developed in 7 of 13 dogs, necessitating shunt removal in 2 dogs and euthanasia in 1. Eight of 11 dogs with long-term follow- up developed complications; the overall mean survival time and the interval in which dogs remained free of clinical signs of pleural effusion were 27 months (range, 1 to 108 months) and 20 months (range, 0.5 to 108 months), respectively. Conclusions and Clinical Relevance—Pleuroperitoneal shunts can effectively palliate clinical signs associated with intractable pleural effusion in dogs. Numerous short- and long-term complications related to the shunt should be expected. Most complications can be successfully managed, but even when shunts are functional some treatments fail because of severe abdominal distension or massive pleural fluid production that overwhelms the functional capacity of the shunt. (J Am Vet Med Assoc 2001;219:1590–1597)Keywords
This publication has 24 references indexed in Scilit:
- Postcaval Thrombosis and Delayed Shunt Migration After Pleuro‐Peritoneal Venous Shunting for Concurrent Chylothorax and Chylous Ascites in a DogVeterinary Surgery, 1996
- Use of video-assisted thoracic surgery in the treatment of chylothoraxThe Annals of Thoracic Surgery, 1994
- Successful treatment of postoperative chylothorax using an external pleuroperitoneal shuntThe Annals of Thoracic Surgery, 1992
- Pleuroperitoneal shunts for refractory chylothorax after operation for congenital heart diseaseThe Annals of Thoracic Surgery, 1992
- Ascites after pleuroperitoneal shuntingCancer, 1990
- Pleuroperitoneal shunt for recurrent malignant pleural effusions.Thorax, 1990
- Management of Intractable Pleural Effusion in a Dog with a Pleuroperitoneal ShuntVeterinary Surgery, 1987
- Pleuroperitoneal Shunt in Recurrent Pleural EffusionsThe Annals of Thoracic Surgery, 1986
- Pleuroperitoneal shunts in the management of neonatal chylothoraxJournal of Pediatric Surgery, 1983
- The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valveBritish Journal of Surgery, 1975